Monoclonal Antibody Diagnostic Reagents Market
Monoclonal antibodies are useful in diagnostic medicine for determining the concentration of certain proteins in blood or urine. For example, a high blood level of a prostate-specific antigen, as assessed by its interaction with a monoclonal antibody, indicates the presence of prostate cancer. Carcinogenic-embryonic antigen (colorectal cancer), prostate specific antigen (expressed in prostate cancer), CA125 (ovarian cancer), CA19-9 (gastrointestinal cancer), CA15-3 antigen, and HER-2/neu proteins are all widely used to detect carcinogenic-embryonic antigen (colorectal cancer), prostate specific antigen (expressed in prostate cancer), and HER-2/neu proteins (breast cancer).
Monoclonal Antibody Diagnostic Reagents Market is expected to grow at a CAGR of 13.5% during the forecast period 2023-2030.
Market Drivers:
The growing usage of monoclonal antibodies in research and development, cancer treatments, and immunological diseases is likely to fuel growth in the worldwide monoclonal antibody diagnostic reagents market. Monoclonal antibody diagnostic kits are becoming more popular for detecting communicable illnesses, such as transfusion-transmissible infections (TTI). According to World Health Organization (WHO) estimates from 2017, over 15 million people die each year in emerging economies as a result of infectious illnesses. Morbidity is also caused by tropical parasitic illnesses such as schitosomiasis and sexually transmitted infections such as syphilis. The development of precise, simple, and stable diagnostic instruments is urgently needed.
Restraints:
Nevertheless, high costs and the requirement of significant time may impede the worldwide monoclonal antibody diagnostic reagents market growth over the forecast period.
Market Opportunities:
As markets in the United States and Europe mature, most players are moving their attention to emerging regions. High expenditures in healthcare and life science research in emerging economies are critical to modernising these nations' laboratory infrastructures. This, in turn, encourages the installation of diagnostic equipment in laboratories, leading to an increase in the use of molecular diagnostics.
Market Challenges:
Clinical laboratories must employ novel technology capable of quick sample detection due to the rapid mutation of microorganisms and the rising emergence of epidemics. Nevertheless, a lack of experienced and technically knowledgeable laboratory staff to operate modern molecular diagnostic devices has stymied their widespread acceptance, particularly in emerging economies.
Segmentation Analysis:
The global Monoclonal Antibody Diagnostic Reagents Market can be segmented based on diagnostic tests, application,
By Diagnostic Tests:
By Application:
Competitive Landscape:
The major companies in Monoclonal Antibody Diagnostic Reagents Market include
Regional Analysis:
Because of its well-established healthcare infrastructure and increased government funding for cancer research and technology for the development of novel diagnostic techniques, North America is likely to dominate the worldwide monoclonal antibody diagnostic reagents market in terms of revenue share.
Trending Topic's
1. Executive Summary
1.1 Introduction to Monoclonal Antibody Diagnostic Reagents Markets
1.2 Monoclonal Antibody Diagnostic Reagents Market Size Outlook, 2021- 2030
1.3 Growth Opportunities in Monoclonal Antibody Diagnostic Reagents Industry
1.4 Winning Strategies for the post-pandemic future
2. Report Guide
2.1 Market Definition and Scope
2.2 Market Segmentation
2.3 Research Methodology
2.4 Forecast Methodology
2.5 List of Abbreviations
3. Growth Opportunity Analysis
3.1 Key Monoclonal Antibody Diagnostic Reagents Market Trends
3.2 Key Monoclonal Antibody Diagnostic Reagents Market Growth Drivers
3.3 Key Monoclonal Antibody Diagnostic Reagents Market Growth Restraints
4 Monoclonal Antibody Diagnostic Reagents Market Outlook – Scenario Analysis
4.1 Low Growth Case Scenario Forecasts
4.2 Reference Growth Case Scenario Forecasts
4.3 High Growth Case Scenario Forecasts
5. Monoclonal Antibody Diagnostic Reagents Market Segmentation- Outlook by Type
5.1 Dot-immunogold Filtration Assay Market Outlook to 2030
5.2 Double Antigen Sandwich Chemiluminescence Method Market Outlook to 2030
5.3 EnzymeLinked Immunosorbent Assay Market Outlook to 2030
5.4 Recombinant Immunoblot Assay Market Outlook to 2030
6. Monoclonal Antibody Diagnostic Reagents Market Segmentation- Outlook by Product
6.1 Hormones Diagnosis Cable Market Outlook to 2030
6.2 Tumor Monitoring Market Outlook to 2030
6.3 Virus Detection Market Outlook to 2030
6.4 Other Market Outlook to 2030
8. North America Monoclonal Antibody Diagnostic Reagents Market Outlook and Opportunities to 2030
8.1 Market Snapshot, 2023
8.2 North America Monoclonal Antibody Diagnostic Reagents Market Growth Opportunities
8.3 North America Monoclonal Antibody Diagnostic Reagents Market Outlook by Application
8.4 North America Monoclonal Antibody Diagnostic Reagents Market Outlook by Type
8.5 North America Monoclonal Antibody Diagnostic Reagents Market Outlook by Country
8.6 United States Monoclonal Antibody Diagnostic Reagents Market Outlook
8.7 Canada Monoclonal Antibody Diagnostic Reagents Market Outlook
8.8 Mexico Monoclonal Antibody Diagnostic Reagents Market Outlook
9. Europe Monoclonal Antibody Diagnostic Reagents Market Outlook and Opportunities to 2030
9.1 Market Snapshot, 2023
9.2 Europe Monoclonal Antibody Diagnostic Reagents Market Outlook by Application
9.3 Europe Monoclonal Antibody Diagnostic Reagents Market Outlook by Type
9.4 Europe Monoclonal Antibody Diagnostic Reagents Market Outlook by Country
9.5 Germany Monoclonal Antibody Diagnostic Reagents Market Outlook
9.6 France Monoclonal Antibody Diagnostic Reagents Market Outlook
9.7 United Kingdom Monoclonal Antibody Diagnostic Reagents Market Outlook
9.8 Spain Monoclonal Antibody Diagnostic Reagents Market Outlook
9.9 Italy Monoclonal Antibody Diagnostic Reagents Market Outlook
9.10 Other Europe Monoclonal Antibody Diagnostic Reagents Market Outlook
10. Asia Pacific Monoclonal Antibody Diagnostic Reagents Market Outlook and Opportunities to 2030
10.1 Market Snapshot, 2023
10.2 Asia Pacific Monoclonal Antibody Diagnostic Reagents Market Outlook by Application
10.3 Asia Pacific Monoclonal Antibody Diagnostic Reagents Market Outlook by Type
10.4 Asia Pacific Monoclonal Antibody Diagnostic Reagents Market Outlook by Country
10.5 China Monoclonal Antibody Diagnostic Reagents Market Outlook
10.6 Japan Monoclonal Antibody Diagnostic Reagents Market Outlook
10.7 India Monoclonal Antibody Diagnostic Reagents Market Outlook
10.8 Other Asia Pacific Monoclonal Antibody Diagnostic Reagents Market Outlook
11. Latin America Monoclonal Antibody Diagnostic Reagents Market Outlook and Opportunities to 2030
11.1 Market Snapshot, 2023
11.2 Latin America Monoclonal Antibody Diagnostic Reagents Market Outlook by Application
11.3 Latin America Monoclonal Antibody Diagnostic Reagents Market Outlook by Type
11.4 Latin America Monoclonal Antibody Diagnostic Reagents Market Outlook by Country
11.5 Brazil Monoclonal Antibody Diagnostic Reagents Market Outlook
11.6 Argentina Monoclonal Antibody Diagnostic Reagents Market Outlook
11.7 Other Latin America Monoclonal Antibody Diagnostic Reagents Market Outlook
12. Middle East and Africa Monoclonal Antibody Diagnostic Reagents Market Outlook and Opportunities to 2030
12.1 Market Snapshot, 2023
12.2 Middle East and Africa Monoclonal Antibody Diagnostic Reagents Market Outlook by Application
12.3 Middle East and Africa Monoclonal Antibody Diagnostic Reagents Market Outlook by Type
12.4 Middle East and Africa Monoclonal Antibody Diagnostic Reagents Market Outlook by Country
12.5 Saudi Arabia Monoclonal Antibody Diagnostic Reagents Market Outlook
12.6 UAE Monoclonal Antibody Diagnostic Reagents Market Outlook
12.7 South Africa Monoclonal Antibody Diagnostic Reagents Market Outlook
12.8 Other Middle East and Africa Monoclonal Antibody Diagnostic Reagents Market Outlook
13 Profiles of major Monoclonal Antibody Diagnostic Reagents Companies
AnaSpec
- Key Statistics
- Business Operations
- Products and Services Offered
- SWOT Analysis
- Financial Analysis
BioGenex
- Key Statistics
- Business Operations
- Products and Services Offered
- SWOT Analysis
- Financial Analysis
Bio-Rad Laboratories
- Key Statistics
- Business Operations
- Products and Services Offered
- SWOT Analysis
- Financial Analysis
Biocare Medical
- Key Statistics
- Business Operations
- Products and Services Offered
- SWOT Analysis
- Financial Analysis
BioVision
- Key Statistics
- Business Operations
- Products and Services Offered
- SWOT Analysis
- Financial Analysis
Celltrion
- Key Statistics
- Business Operations
- Products and Services Offered
- SWOT Analysis
- Financial Analysis
Creative Diagnostics
- Key Statistics
- Business Operations
- Products and Services Offered
- SWOT Analysis
- Financial Analysis
Genway Biotech
- Key Statistics
- Business Operations
- Products and Services Offered
- SWOT Analysis
- Financial Analysis
Innovent Biologics
- Key Statistics
- Business Operations
- Products and Services Offered
- SWOT Analysis
- Financial Analysis
Medix Biochemica
- Key Statistics
- Business Operations
- Products and Services Offered
- SWOT Analysis
- Financial Analysis
Qiagen NV
- Key Statistics
- Business Operations
- Products and Services Offered
- SWOT Analysis
- Financial Analysis
Teva Pharmaceuticals Ltd
- Key Statistics
- Business Operations
- Products and Services Offered
- SWOT Analysis
- Financial Analysis
14. Appendix
14.1 Publisher’s Expertise
14.2 List of Tables and Charts
14.3 List of Exhibits
14.4 Legal Disclaimer